HK1109151A1 - Aspartyl protease inhibitors - Google Patents
Aspartyl protease inhibitorsInfo
- Publication number
- HK1109151A1 HK1109151A1 HK08103079.0A HK08103079A HK1109151A1 HK 1109151 A1 HK1109151 A1 HK 1109151A1 HK 08103079 A HK08103079 A HK 08103079A HK 1109151 A1 HK1109151 A1 HK 1109151A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protease inhibitors
- aspartyl protease
- aspartyl
- inhibitors
- protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69032605P | 2005-06-14 | 2005-06-14 | |
PCT/US2006/022698 WO2006138192A1 (en) | 2005-06-14 | 2006-06-12 | Aspartyl protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1109151A1 true HK1109151A1 (en) | 2008-05-30 |
Family
ID=37074234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08103079.0A HK1109151A1 (en) | 2005-06-14 | 2008-03-18 | Aspartyl protease inhibitors |
Country Status (18)
Country | Link |
---|---|
US (1) | US7759354B2 (ko) |
EP (1) | EP1896477B1 (ko) |
JP (1) | JP2008543840A (ko) |
KR (1) | KR20080031189A (ko) |
CN (1) | CN101198609A (ko) |
AR (1) | AR054620A1 (ko) |
AT (1) | ATE482214T1 (ko) |
AU (1) | AU2006259675A1 (ko) |
CA (1) | CA2610812A1 (ko) |
DE (1) | DE602006017073D1 (ko) |
ES (1) | ES2350854T3 (ko) |
HK (1) | HK1109151A1 (ko) |
IL (1) | IL187623A0 (ko) |
MX (1) | MX2007016175A (ko) |
PE (1) | PE20070018A1 (ko) |
TW (1) | TW200716644A (ko) |
WO (1) | WO2006138192A1 (ko) |
ZA (1) | ZA200710337B (ko) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
WO2006138192A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
EP1896478B1 (en) | 2005-06-14 | 2014-05-21 | Merck Sharp & Dohme Corp. | Aspartyl protease inhibitors |
RU2416603C9 (ru) | 2005-10-25 | 2012-06-20 | Сионоги Энд Ко., Лтд. | Производные аминодигидротиазина |
AR061264A1 (es) | 2006-06-12 | 2008-08-13 | Schering Corp | Inhibidores de aspartil-proteasas derivados de pirimidina, composiciones farmaceuticas que los contienen y usos para tratar enfermedades cognitivas o neurodegenerativas, y como inhibidores del virus vih. |
EP2061771A1 (en) * | 2006-12-12 | 2009-05-27 | Schering Corporation | Aspartyl protease inhibitors containing a tricyclic ring system |
MX2009006228A (es) | 2006-12-12 | 2009-06-22 | Schering Corp | Inhibidores de aspartil proteasa. |
WO2008133273A1 (ja) | 2007-04-24 | 2008-11-06 | Shionogi & Co., Ltd. | アルツハイマー症治療用医薬組成物 |
ES2476605T3 (es) | 2007-04-24 | 2014-07-15 | Shionogi & Co., Ltd. | Derivados de aminohidrotiazina sustituidos con grupos cíclicos |
WO2009032277A1 (en) | 2007-09-06 | 2009-03-12 | Schering Corporation | Gamma secretase modulators |
JP2011503002A (ja) | 2007-11-05 | 2011-01-27 | シェーリング コーポレイション | γセクレターゼ調節剤 |
WO2009076352A1 (en) | 2007-12-11 | 2009-06-18 | Schering Corporation | Gamma secretase modulators |
JP2011518224A (ja) | 2008-04-22 | 2011-06-23 | シェーリング コーポレイション | Bace−1阻害剤としてのチオフェニル置換2−イミノ−3−メチルピロロピリミジノン化合物、組成物、およびそれらの使用 |
NZ589590A (en) | 2008-06-13 | 2012-05-25 | Shionogi & Co | Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity |
WO2010021680A2 (en) * | 2008-08-19 | 2010-02-25 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
WO2010047372A1 (ja) | 2008-10-22 | 2010-04-29 | 塩野義製薬株式会社 | Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体 |
RU2011123862A (ru) | 2008-11-13 | 2012-12-20 | Шеринг Корпорейшн | Модуляторы гамма-секретазы |
WO2010075204A2 (en) | 2008-12-22 | 2010-07-01 | Schering Corporation | Gamma secretase modulators |
CA2747744A1 (en) | 2008-12-22 | 2010-07-01 | Theodros Asberom | Gamma secretase modulators |
DK2406240T3 (en) | 2009-03-13 | 2016-02-01 | Vitae Pharmaceuticals Inc | INHIBITORS OF BETA-secretase |
EP2443121A2 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
EP2443119A1 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
US20120232108A1 (en) | 2009-06-16 | 2012-09-13 | Xianhai Huang | Gamma secretase modulators |
EP2485920B1 (en) | 2009-10-08 | 2016-04-27 | Merck Sharp & Dohme Corp. | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
WO2011044184A1 (en) | 2009-10-08 | 2011-04-14 | Schering Corporation | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
US8563543B2 (en) | 2009-10-08 | 2013-10-22 | Merck Sharp & Dohme Corp. | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
RU2012129168A (ru) | 2009-12-11 | 2014-01-20 | Сионоги Энд Ко. Лтд. | Производные оксазина |
WO2011106414A1 (en) | 2010-02-24 | 2011-09-01 | Dillard Lawrence W | Inhibitors of beta-secretase |
EP2634188A4 (en) | 2010-10-29 | 2014-05-07 | Shionogi & Co | FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE |
AU2011321427A1 (en) | 2010-10-29 | 2013-05-02 | Shionogi & Co., Ltd. | Naphthyridine derivative |
WO2012138734A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
EP2694521B1 (en) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
EP2703399A4 (en) | 2011-04-26 | 2014-10-15 | Shionogi & Co | OXAZINE DERIVATIVE AND BACE-1 HEMMER THEREOF |
EP2747769B1 (en) | 2011-08-22 | 2017-08-02 | Merck Sharp & Dohme Corp. | 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use |
TWI557112B (zh) | 2012-03-05 | 2016-11-11 | 百靈佳殷格翰國際股份有限公司 | β-分泌酶抑制劑 |
CN104270945B (zh) | 2012-03-19 | 2017-03-29 | 巴克老龄化研究所 | App特异性bace抑制剂(asbi)及其用途 |
TW201422592A (zh) | 2012-08-27 | 2014-06-16 | Boehringer Ingelheim Int | β-分泌酶抑制劑 |
US9290477B2 (en) | 2012-09-28 | 2016-03-22 | Vitae Pharmaceuticals, Inc. | Inhibitors of β-secretase |
WO2014062553A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2014062549A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
EP2912035A4 (en) | 2012-10-24 | 2016-06-15 | Shionogi & Co | DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY |
CA2899938C (en) | 2013-02-12 | 2021-10-19 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
CA2902080A1 (en) | 2013-02-25 | 2014-08-28 | Merck Patent Gmbh | 2-amino-3,4-dihydroquinazoline derivatives and the use thereof as cathepsin d inhibitors |
US11766435B2 (en) | 2016-02-18 | 2023-09-26 | Merck Sharp & Dohme Llc | N3-substituted iminopyrimidinones as antimalarial agents |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3865836A (en) * | 1972-12-08 | 1975-02-11 | Janssen Pharmaceutica Nv | Bicyclic imidazoles |
JPS5946518B2 (ja) * | 1976-12-23 | 1984-11-13 | 第一製薬株式会社 | 2,2−又は3,3−ジ置換−イミダゾ〔1,2−a〕〔1,3〕ジアザシクロアルカン類 |
GB8312892D0 (en) * | 1983-05-11 | 1983-06-15 | Raychem Ltd | Electrical insulator |
JPS60173546A (ja) * | 1984-02-20 | 1985-09-06 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料の現像処理方法 |
IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
WO1993004047A1 (en) | 1991-08-16 | 1993-03-04 | Merck & Co., Inc. | Quinazoline derivatives as inhibitors of hiv reverse transcriptase |
US5958920A (en) * | 1994-12-02 | 1999-09-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aralkyl diazabicycloalkane derivatives for CNS disorders |
JP2000514456A (ja) * | 1996-07-15 | 2000-10-31 | ブリストル―マイヤーズ・スクイブ・カンパニー | ファルネシルプロテイントランスフェラーゼのチアジオキソベンゾジアゼピン阻害剤 |
FR2756282B1 (fr) * | 1996-11-22 | 1998-12-31 | Elf Aquitaine | Procede de synthese d'esters de l'acide mercapto-3-propionique |
JP2003504301A (ja) * | 1998-04-01 | 2003-02-04 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | インテグリンアンタゴニスト |
EP1340760A1 (en) | 2002-02-28 | 2003-09-03 | Sanofi-Synthelabo | Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives |
EP1295885A1 (en) * | 2001-09-21 | 2003-03-26 | Sanofi-Synthelabo | Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives |
EP1340761A1 (en) * | 2002-02-28 | 2003-09-03 | Sanofi-Synthelabo | Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives |
MXPA04002632A (es) * | 2001-09-21 | 2004-07-08 | Mitsubishin Pharma Corp | Derivados de 2-pirimidinil-6,7,8,9-tetrahidropirimido-[1,2-a] pirimidin-4-ona y 7-pirimidinil-2,3. dihidroimidazo [1,2-a] pirimidim-5 (1h)-ona substituidos para desordenes neurodegenerativos. |
CA2534950A1 (en) | 2003-08-08 | 2005-02-24 | Schering Corporation | Cyclic amine bace-1 inhibitors having a benzamide substituent |
JP4472700B2 (ja) | 2003-08-08 | 2010-06-02 | シェーリング コーポレイション | 複素環置換基を有する環状アミンbase−1阻害剤 |
EP1701772A4 (en) | 2003-11-21 | 2012-03-28 | Univ Johns Hopkins | BIOMOLECULAR SEPARATION PATTERNS AND USES |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
SG163508A1 (en) * | 2003-12-15 | 2010-08-30 | Schering Corp | Heterocyclic aspartyl protease inhibitors |
WO2005073365A1 (ja) | 2004-01-29 | 2005-08-11 | Japan Tissue Engineering Co., Ltd. | 移植用細胞の処理方法、細胞懸濁液、移植用補綴物、および損傷部位の治療方法 |
DE102004007076A1 (de) * | 2004-02-13 | 2005-08-25 | Bayer Cropscience Ag | Imidazolopyrimidine |
BRPI0512213A (pt) * | 2004-06-16 | 2008-02-19 | Wyeth Corp | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto |
EP1758907B1 (en) | 2004-06-16 | 2009-02-18 | Wyeth | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
ATE491693T1 (de) | 2004-07-22 | 2011-01-15 | Schering Corp | Substituierte amide als inhibitoren der beta- sekretase |
EP1781644B1 (en) | 2004-07-28 | 2008-05-28 | Schering Corporation | Macrocyclic beta-secretase inhibitors |
JP2008515989A (ja) | 2004-10-13 | 2008-05-15 | メルク エンド カムパニー インコーポレーテッド | アルツハイマー病を治療するためのβ−セクレターゼ阻害薬として有用なスピロピペリジン化合物 |
JP2008516945A (ja) | 2004-10-15 | 2008-05-22 | アストラゼネカ・アクチエボラーグ | 置換されたアミノ化合物およびそれらの使用 |
US7534807B2 (en) * | 2005-02-18 | 2009-05-19 | North Carolina State University | De novo synthesis of bacteriochlorins |
EP1896478B1 (en) | 2005-06-14 | 2014-05-21 | Merck Sharp & Dohme Corp. | Aspartyl protease inhibitors |
WO2006138192A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
WO2006138217A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
EP2194047A1 (en) | 2005-06-14 | 2010-06-09 | Schering Corporation | Preparation and use of aspartyl protease inhibitors |
AR056865A1 (es) | 2005-06-14 | 2007-10-31 | Schering Corp | Heterociclos nitrogenados y su uso como inhibidores de proteasas, composiciones farmaceuticas |
MX2007016185A (es) | 2005-06-14 | 2008-03-07 | Schering Corp | Inhibidores de aspartil proteasa heterociclicos macrociclicos. |
US20080113957A1 (en) | 2005-06-14 | 2008-05-15 | Mckittrick Brian | Preparation and use of compounds as protease inhibitors |
CA2620223A1 (en) * | 2005-09-02 | 2007-03-08 | Abbott Laboratories | Novel imidazo based heterocycles |
US7763606B2 (en) | 2005-10-27 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
EP1943246A1 (en) | 2005-10-31 | 2008-07-16 | Schering Corporation | Aspartyl protease inhibitors |
NZ569814A (en) | 2006-01-18 | 2011-10-28 | Schering Corp | Cannibinoid receptor modulators |
AR061264A1 (es) | 2006-06-12 | 2008-08-13 | Schering Corp | Inhibidores de aspartil-proteasas derivados de pirimidina, composiciones farmaceuticas que los contienen y usos para tratar enfermedades cognitivas o neurodegenerativas, y como inhibidores del virus vih. |
WO2008063558A2 (en) | 2006-11-17 | 2008-05-29 | Schering Corporation | Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders |
MX2009006228A (es) | 2006-12-12 | 2009-06-22 | Schering Corp | Inhibidores de aspartil proteasa. |
EP2061771A1 (en) | 2006-12-12 | 2009-05-27 | Schering Corporation | Aspartyl protease inhibitors containing a tricyclic ring system |
-
2006
- 2006-06-12 WO PCT/US2006/022698 patent/WO2006138192A1/en active Application Filing
- 2006-06-12 MX MX2007016175A patent/MX2007016175A/es unknown
- 2006-06-12 US US11/451,074 patent/US7759354B2/en active Active
- 2006-06-12 DE DE602006017073T patent/DE602006017073D1/de active Active
- 2006-06-12 KR KR1020077029729A patent/KR20080031189A/ko not_active Application Discontinuation
- 2006-06-12 AT AT06784753T patent/ATE482214T1/de not_active IP Right Cessation
- 2006-06-12 CA CA002610812A patent/CA2610812A1/en not_active Abandoned
- 2006-06-12 CN CNA2006800212013A patent/CN101198609A/zh active Pending
- 2006-06-12 AR ARP060102466A patent/AR054620A1/es not_active Application Discontinuation
- 2006-06-12 AU AU2006259675A patent/AU2006259675A1/en not_active Abandoned
- 2006-06-12 JP JP2008516963A patent/JP2008543840A/ja active Pending
- 2006-06-12 ES ES06784753T patent/ES2350854T3/es active Active
- 2006-06-12 EP EP06784753A patent/EP1896477B1/en active Active
- 2006-06-13 TW TW095121028A patent/TW200716644A/zh unknown
- 2006-06-13 PE PE2006000661A patent/PE20070018A1/es not_active Application Discontinuation
-
2007
- 2007-11-25 IL IL187623A patent/IL187623A0/en unknown
- 2007-11-28 ZA ZA200710337A patent/ZA200710337B/xx unknown
-
2008
- 2008-03-18 HK HK08103079.0A patent/HK1109151A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1896477B1 (en) | 2010-09-22 |
CN101198609A (zh) | 2008-06-11 |
AR054620A1 (es) | 2007-07-04 |
JP2008543840A (ja) | 2008-12-04 |
DE602006017073D1 (en) | 2010-11-04 |
PE20070018A1 (es) | 2007-03-08 |
KR20080031189A (ko) | 2008-04-08 |
ATE482214T1 (de) | 2010-10-15 |
IL187623A0 (en) | 2008-03-20 |
WO2006138192A1 (en) | 2006-12-28 |
EP1896477A1 (en) | 2008-03-12 |
ZA200710337B (en) | 2008-12-31 |
MX2007016175A (es) | 2008-03-07 |
US7759354B2 (en) | 2010-07-20 |
ES2350854T3 (es) | 2011-01-27 |
CA2610812A1 (en) | 2006-12-28 |
TW200716644A (en) | 2007-05-01 |
US20060281730A1 (en) | 2006-12-14 |
AU2006259675A1 (en) | 2006-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL187815A0 (en) | Aspartyl protease inhibitors | |
IL187814A0 (en) | Aspartyl protease inhibitors | |
HK1109151A1 (en) | Aspartyl protease inhibitors | |
HK1119680A1 (en) | Heterocyclic aspartyl protease inhibitors | |
HRP20160876T1 (hr) | Heterociklični inhibitori aspartil proteaze | |
HK1106430A1 (en) | Heterocyclic aspartyl protease inhibitors | |
IL195592A0 (en) | Heterocyclic aspartyl protease inhibitors | |
EP1981519A4 (en) | PROTEASE INHIBITION | |
HK1121459A1 (en) | Aspartic protease inhibitors | |
HK1096956A1 (en) | Cysteine protease inhibitors | |
EP1732906A4 (en) | 2-AMINOTHIAZOLE COMPOUNDS USEFUL AS ASPARTYLE-PROTEASE INHIBITORS | |
ZA200702836B (en) | Diaminoalkane aspartic protease inhibitors | |
GB0513841D0 (en) | Cysteine protease inhibitors | |
IL177055A0 (en) | Silinae compounds as cysteine protease inhibitors | |
IL183850A0 (en) | Hiv protease inhibitors | |
EP2064177A4 (en) | PROTEASE INHIBITORS | |
EP1855672A4 (en) | HIV PROTEASE INHIBITORS | |
GB0513839D0 (en) | Cysteine protease inhibitors | |
GB0513840D0 (en) | Cysteine protease inhibitors | |
ZA200804025B (en) | Aspartic protease inhibitors | |
ZA200706305B (en) | HIV protease inhibitors | |
GB0507627D0 (en) | Protease inhibitors | |
GB0507628D0 (en) | Protease inhibitors | |
GB0513842D0 (en) | Cysteine protease inhibitors | |
GB0513837D0 (en) | Cysteine protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140612 |